Trade Bristol Myers ^BMY

Bristol-Myers Squibb (NYSE:BMY) Stock Position Lowered by Flagship Harbor Advisors LLC

Dynamic Advisor Solutions LLC Decreases Position in Bristol-Myers Squibb (NYSE:BMY)

Linden Thomas Advisory Services LLC Lowers Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)

1834 Investment Advisors Co. Has $9.24 Million Stake in Bristol-Myers Squibb (NYSE:BMY)

Guerra Pan Advisors LLC Buys New Shares in Bristol-Myers Squibb (NYSE:BMY)

10,527 Shares in Bristol-Myers Squibb (NYSE:BMY) Purchased by Clarendon Private LLC

RTD Financial Advisors Inc. Sells 8,737 Shares of Bristol-Myers Squibb (NYSE:BMY)

First Citizens Bank & Trust Co. Has $6.11 Million Holdings in Bristol-Myers Squibb (NYSE:BMY)

Moody Lynn & Lieberson LLC Boosts Stake in Bristol-Myers Squibb (NYSE:BMY)

Advocate Group LLC Increases Holdings in Bristol-Myers Squibb (NYSE:BMY)

Toth Financial Advisory Corp Has $4.13 Million Position in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by AEGON ASSET MANAGEMENT UK Plc

Grimes & Company Inc. Cuts Position in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Goelzer Investment Management Inc.

Cornerstone Wealth Management LLC Has $1.46 Million Stake in Bristol-Myers Squibb (NYSE:BMY)

Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial

Neumann Capital Management LLC Has $1.12 Million Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)

Silver Lake Advisory LLC Raises Position in Bristol-Myers Squibb (NYSE:BMY)

MFA Wealth Services Acquires Shares of 6,360 Bristol-Myers Squibb (NYSE:BMY)

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Sells 61,128 Shares of Bristol-Myers Squibb (NYSE:BMY)

Janney Montgomery Scott LLC Has $54 Million Stake in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Bought by Atomi Financial Group Inc.

Bartlett & CO. Wealth Management LLC Sells 5,860 Shares of Bristol-Myers Squibb (NYSE:BMY)

Hudson Capital Management LLC Lowers Stock Position in Bristol-Myers Squibb (NYSE:BMY)

Global Trust Asset Management LLC Has $102,000 Position in Bristol-Myers Squibb (NYSE:BMY)

Nisa Investment Advisors LLC Sells 9,417 Shares of Bristol-Myers Squibb (NYSE:BMY)

Interstitial Lung Disease Therapeutics Market Size in the 7MM is anticipated to increase by 2032 and according to DelveInsight

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Bourne Lent Asset Management Inc.

Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by Aspire Private Capital LLC

Dakota Wealth Management Acquires 205,772 Shares of Bristol-Myers Squibb (NYSE:BMY)

Genesis Private Wealth LLC Makes New Investment in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Stock Holdings Boosted by Fort Washington Investment Advisors Inc. OH

Bristol-Myers Squibb (NYSE:BMY) Stock Position Raised by Pure Financial Advisors LLC

Bristol-Myers Squibb (NYSE:BMY) Shares Bought by Pure Financial Advisors LLC

Crossmark Global Holdings Inc. Buys 5,488 Shares of Bristol-Myers Squibb (NYSE:BMY)

Aspiriant LLC Sells 520 Shares of Bristol-Myers Squibb (NYSE:BMY)

Myelodysplastic Syndrome Therapeutics Market Size in the 7MM was ~USD 2,800 Million in 2023, is expected to grow by 2034 | DelveInsight

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by First United Bank & Trust

Why Is Bristol-Myers Squibb Company (BMY) Among the Best High-Yield Dividend Stocks to Invest In?

Bristol-Myers Squibb (NYSE:BMY) Shares Bought by Corundum Group Inc.

BigSur Wealth Management LLC Decreases Holdings in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Acquired by UMB Bank n.a.

M.E. Allison & CO. Inc. Purchases New Position in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Stock Position Lessened by Gilman Hill Asset Management LLC

Krilogy Financial LLC Invests $570,000 in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Acquired by Merit Financial Group LLC

Trust Co. of Vermont Has $2.55 Million Position in Bristol-Myers Squibb (NYSE:BMY)

Integrated Investment Consultants LLC Buys 14,292 Shares of Bristol-Myers Squibb (NYSE:BMY)

Arkadios Wealth Advisors Buys 12,992 Shares of Bristol-Myers Squibb (NYSE:BMY)

Cohen Klingenstein LLC Sells 21,000 Shares of Bristol-Myers Squibb (NYSE:BMY)

Romano Brothers AND Company Sells 6,801 Shares of Bristol-Myers Squibb (NYSE:BMY)

Brooklyn Investment Group Raises Stake in Bristol-Myers Squibb (NYSE:BMY)

HB Wealth Management LLC Acquires 11,023 Shares of Bristol-Myers Squibb (NYSE:BMY)

Hennion & Walsh Asset Management Inc. Has $1.34 Million Position in Bristol-Myers Squibb (NYSE:BMY)

Why Bristol-Myers Squibb (BMY) Is One of the Best Cheap Stocks to Buy for 2025?

Woodstock Corp Has $2.96 Million Stake in Bristol-Myers Squibb (NYSE:BMY)

Relyea Zuckerberg Hanson LLC Acquires 1,101 Shares of Bristol-Myers Squibb (NYSE:BMY)

Wedge Capital Management L L P NC Decreases Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)

Ritholtz Wealth Management Has $2.23 Million Position in Bristol-Myers Squibb (NYSE:BMY)

Bristol Myers Squibb Foundation, Texas Children's Global HOPE, & Baylor College of Medicine Global Health Launch Program to Combat Sickle Cell Disease in Sub-Saharan Africa | Morningstar

We're buying more of an underappreciated stock and downgrading another that has broken out

Avanza Fonder AB Makes New $12.34 Million Investment in Bristol-Myers Squibb (NYSE:BMY)

Pinnacle Bancorp Inc. Buys 600 Shares of Bristol-Myers Squibb (NYSE:BMY)

Park Avenue Securities LLC Purchases 13,952 Shares of Bristol-Myers Squibb (NYSE:BMY)

Bristol Myers Squibb (BMY) Stock Dips While Market Gains: Key Facts - January 17, 2025 - Zacks.com

HCR Wealth Advisors Has $593,000 Holdings in Bristol-Myers Squibb (NYSE:BMY)

8,620 Shares in Bristol-Myers Squibb (NYSE:BMY) Acquired by Contravisory Investment Management Inc.

Bristol Myers Squibb discloses new IKZF1-4 degraders | BioWorld

SS&H Financial Advisors Inc. Boosts Stake in Bristol-Myers Squibb (NYSE:BMY)

Bristol Myers Squibb: Schizophrenia drug Cobenfy could treat Alzheimer's

Meyer Handelman Co. Sells 10,723 Shares of Bristol-Myers Squibb (NYSE:BMY)

Radnor Capital Management LLC Reduces Stake in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Stock Position Increased by 626 Financial LLC

Acropolis Investment Management LLC Has $1.92 Million Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)

Positive Outlook for Bristol-Myers Squibb with Promising Market Access and Societal Benefits of Cobenfy

Bristol-Myers Squibb (NYSE:BMY) Shares Bought by Marcum Wealth LLC

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Wright Investors Service Inc.

FNY Investment Advisers LLC Acquires 12,360 Shares of Bristol-Myers Squibb (NYSE:BMY)

Friedenthal Financial Acquires Shares of 879 Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Stake Raised by Brookstone Capital Management

Randomized clinical trial of a digital integrative medicine intervention among patients undergoing active cancer treatment

Bristol-Myers Squibb (NYSE:BMY) Stake Reduced by Burns J W & Co. Inc. NY

Courier Capital LLC Sells 4,607 Shares of Bristol-Myers Squibb (NYSE:BMY)

Here is What to Know Beyond Why Bristol Myers Squibb Company (BMY) is a Trending Stock - January 14, 2025 - Zacks.com

Burns J W & Co. Inc. NY Has $1.85 Million Position in Bristol-Myers Squibb (NYSE:BMY)

Mid American Wealth Advisory Group Inc. Lowers Stock Position in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb Co (BMY) Strengthens Collaboration with ArsenalBio for Advanced T Cell ...

Capital Investment Advisors LLC Has $14.02 Million Stake in Bristol-Myers Squibb (NYSE:BMY)

CAR T Cell Therapy Breyanzi® (lisocabtagene maraleucel) Approved for Second-Line Relapsed or Refractory Diffuse Large B-cell Lymphoma

ArsenalBio and Bristol Myers Squibb Achieve Milestone for AB-4000 Series as Part of Ongoing Multi-Program Collaboration to Advance Next-Generation T Cell Therapies for Solid Tumors | The Manila Times

-- Bristol Myers Squibb exercises an exclusive license optio

ArsenalBios Says Bristol Myers Squibb Exercises Exclusive License Option For AB-4000 Series Programs

Bristol Myers Squibb licenses new CAR T therapy By Investing.com

Other news to note for Jan. 13, 2025 | BioWorld

Will Trump Actually Do Tariffs? Impact on Gold

Bitcoin Price Prediction and Trump Crypto Insights

How Trump's Tariffs Impact USD to MXN and CAD USD Rate Forecast

Morning Note: Gold Steadies as Markets Await Fed’s First 2025 Rate Decision

Week Ahead: China Is On Holiday, But The BoC, The Fed, And The ECB Will Be Busy With The First 2025 Rate Announcements 

Trump Crypto Analysis and Insights

Commodity Gold and Metal Prices Today

BoJ Interest Rate Hike ; USD to JPY Forecast